key: cord-0832319-fbkujspe
authors: Malik, Vivek Singh; Ravindra, Khaiwal; Attri, Savita Verma; Bhadada, Sanjay Kumar; Singh, Meenu
title: Higher body mass index is an important risk factor in COVID-19 patients: a systematic review and meta-analysis
date: 2020-07-24
journal: Environ Sci Pollut Res Int
DOI: 10.1007/s11356-020-10132-4
sha: 031c61ffbe778d39ba8aa346e0a012eb5007fc75
doc_id: 832319
cord_uid: fbkujspe

Globally, both obesity and underweight are severe health risks for various diseases. The current study systematically examined the emerging evidence to identify an association between body mass index (BMI) and COVID-19 disease outcome. Online literature databases (e.g., Google Scholar, PubMed, MEDLINE, EMBASE, Scopus, Medrixv and BioRixv) were screened following standard search strategy having the appropriate keyword such as “Obesity”, “Underweight”, “BMI”, “Body Mass Index”, “2019-nCov”, “COVID-19, “novel coronavirus”, “coronavirus disease”. Studies published till 20(th) April 2020 were included without language restriction. These studies include case reports, case series, cohort, and any other which reported BMI, overweight/obesity or underweight, and its complication with COVID-19 disease. This study observed COVID-19 infection among BMI < 25 kg/m(2) with prevalence of 0.60 (95%CI: 0.34–0.86, I(2) = − 76.77) as compared to the 0.34 (95%CI: 0.23–0.44, I(2) = 53.45% heterogeneity) having BMI > 25 kg/m(2). The results of the current study show that BMI plays a significant role in COVID-19 severity in all age groups, especially the older individuals. A panel of doctors and nursing staff should review COVID-19 patients with higher BMI with other co-morbidities (diabetes and hypertension), and they should be given increased vigilance, priority in testing, and treatment to control the associated co-morbidities. Further, the COVID-19 patients whose illness entered 7–10 days, age > 50 years, and elevated CRP levels should be given additional medical considerations. Our finding showed that the population and patients with high BMI have moderate to high risk of medical complications with COVID-19, and hence, their health status should be monitored more frequently including monitoring of blood pressure and blood glucose.

Being overweight, obese, and underweight may have a major risk factor for multiple disorders in the later stage of life. Earlier studies have shown a relationship between BMI and mortality among diabetic patients (Chang et al. 2016) , mental behavioral, neurological (Bhaskaran et al. 2018) , and Parkinson's disease (Chen et al. 2014) .

Influence of infection on obesity A U-shaped (non-linear relationship) elevated infection rate was seen among overweight/obese and underweight old age persons (Dobner and Kaser 2018) , increased CVD risk with greater malignancy rates (Gluvic et al. 2016; Tune et al. 2017; Vucenik and Stains 2012) , and obesity with impaired immune responses was seen (Carbone et al. 2016) . Overweight/obesity was reported as a risk factor for Clostridium difficile colitis, pneumonia, bacteremia infections (Falagas and Kompoti 2006; Huttunen et al. 2013) , and increased surgical site infection (Crabtree et al. 2004; Lillenfeld et al. 1988; Olsen et al. 2003; Thelwall et al. 2015; Tjeertes et al. 2015; Vilar-Compte et al. 2000; Zahr et al. 2011) . Similarly, waist circumference was reported as a better predictor of septicemia than BMI (Wang et al. 2013) . In a study, adipose tissue serves as a source for human influenza A virus, Trypanosoma gondi, HIV, adenovirus Ad-36, cytomegalovirus, and mycobacterium tuberculosis (Kassir 2020) . The elderly population is reported to be more susceptible to infections (Dorner et al. 2010a) . Higher mortality risks of influenza were reported among the underweight and obese old population (L. Yang et al. 2013) .

Obesity and coronavirus infection In many countries, the obese population is more vulnerable to most of the noncommunicable diseases. Further, the COVID-19 pandemic has put this population at higher risk (Dayal 2020) . The measures introduced in some countries, e.g., restriction on leaving home for several weeks even for daily walk, will have an impact on mobility, and these infection control measures resulted in physical inactivity, and even short periods of restriction can increase the risk of metabolic disease in future. Overweight and obesity among severe COVID-19 patients were reported as an independent risk factor (Jose and Manuel 2020) . Increased adiposity undermines the pulmonary function contributing the viral pathogenesis as a secondary cause of infection (Dorner et al. 2010 ) has been reported in obese among older individuals (> 60 years of age) (Andersen et al. 2016) . Following the 2009 influenza A virus H 1 N 1 pandemic (Sun et al. 2016 ) and adult respiratory distress syndrome (ARDS) (Ni et al. 2017) , obesity was reported as a risk factor. Decreased mortality due to ventilator-induced lung injury resulting in chronic pro-inflammatory status in obese patients has been reported (Repine and Fernandez-Bustamante 2013) . Infection of influenza A showed that overweight/obesity risk elevates with virus shedding (42% longer) duration among symptomatic patients with obesity (Milner et al. 2015) . In H 1 N 1 disease, obesity was reported as a risk factor with increased hospitalization and death rates (Maier et al. 2018) . Obesity has been shown to increase vulnerability to infections, serving as a risk factor among COVID-19 patient's mortality rate (Misumi et al. 2019) . Potential confounders for obesity and infection risk: smoking (Baik et al. 2000; Nuorti et al. 2000) , well-being (Lasselin et al. 2016) , physical activity (Krüger et al. 2016) , weight loss (Dobner and Kaser 2018) , co-morbidities (Pearson-Stuttard et al. 2016) , and nutrition (Urwin et al. 2014 ) are reported independent of age and sex.

Search strategy PRISMA guideline was used for this metaanalysis (Moher et al. 2009 ). Boolean operators: (BMI) AND (COVID-19), (Obesity) AND (COVID-19), ((Underweight) AND (COVID-19)) OR (CASRS-Cov-2), (BMI) OR (Body Mass Index) AND (COVID-19) were used for PubMed database and for Google Scholar, MEDLINE, EMBASE, Scopus, Medrixv and BioRixv using appropriate keywords (e.g., "Obesity", "BMI", "Body Mass Index", "2019-nCov", "COVID-19, "novel coronavirus", "coronavirus disease"). The study included published literature without language restriction until 20 th April 2020.

Selection criteria (inclusion/exclusion) Studies with the following conditions had included for the meta-analysis: (1) case report, case series, and cohort studies design; (2) BMI assessment > 25 kg/m 2 and < 25 kg/m 2 reported; (3) indicating the risk ratio and/or odds ratio for the obesity risk; (4) studies reporting cross-sectional were excluded; (5) age and gender were not kept as a bar for inclusion; (6) for meta-analysis, we included BMI with reported COVID-19 infections (clinical, laboratory, or both confirmed); and (7) definition of severe COVID-19 was taken .

Data extraction Details of authors, total sample size, and numbers reported for obesity and other conditions, e.g., comorbidity (obesity) and clinical condition (critical/severe), were extracted and recorded independently. Data extraction was accomplished by two reviewers (Dr. Khaiwal Ravindra and Dr. Neha Chanana). Any disagreement was resolved by joint discussion. To minimize the risk of duplication, data were carefully handled. Continuous variable (BMI) was expressed as mean ± SD/median and IQR (interquartile range). The systematic review include case reports, case series, and observational and any other study types of study design which reported obesity and or underweight or its complication of COVID-19 infection. Studies for meta-analysis were pooled only if the outcome measured in the same way by all studies.

Quality assessment The Newcastle-Ottawa scale for cohort studies was used for quality evaluation of the selected studies (Wells 2014) . This scale was applied because most of the studies in this study fall under cohort studies (retrospective), analyzing the other studies by covering broad spectra of study design. However, another study used the modified Newcastle-Ottawa scale for cohort and case-control study design (Codipilly et al. 2018) .

Statistical analysis and data synthesis After extracting the results of the studies, the effects of BMI on COVID-19 patients were pooled and were examined using the random effects method. For continuous outcome, standard error (SE) with 95%CI was calculated. The heterogeneity (I 2 statistic) was assessed between studies. Higgins and colleagues suggested I 2 values 25% (low), 50% (moderate), and 75% (high), indicating the existence of heterogeneity (Ioannidis et al. 2007; Higgins 2003; Higgins and Thompson 2002) . Data analysis was undertaken using Microsoft Excel (Neyeloff et al. 2012) .

Literature search Literature searching and screening was done according to PRISMA chart, as shown in Fig. 1 publications due to duplicates and not relevant to study criteria, only 37 research papers were taken for the fulltext paper. Finally, 14 articles that met the inclusion criteria were included in the quantitative synthesis of the current systematic review.

The main characteristics are summarized in Table 1 . All published research papers fall under observational (cohort) study design. Most of the studies are from China, the USA, and France. The study included articles published/available online till 20 th April 2020. About the obesity criteria, BMI > 25 kg/m 2 was considered as also described in selected studies.

Quality assessment The Newcastle-Ottawa Scale (for cohort studies) was used for the qualitative evaluation of the included studies (Wells 2014) . The risk of bias was assessed based on three domains, i.e., selection, comparability, and outcome, as highlighted in Table 2 .

Publication bias This study included published studies, as well as unpublished literature on MedRxiv and Bioxiv, as long as it meets study inclusion criteria. Possible publication bias was not calculated due to the limited power among studies, and the outcome was < 10 for funnel plot (Lau et al. 2006 ).

The outcomes of the meta-analysis (Table 3) and forest plot (Figs. 2 and 3 ) are shown. A random-effects model (I 2 = 53.45%) was used on 9 articles for those reported ≥ 25 BMI kg/m 2 for COVID-19 infection involving 689 patients to analyze the risk factors of ≥ 25 BMI kg/m 2 [prevalence, 95%CI: 0.34 (0.23-0.44)] for patients with COVID-19 than those of having < 25 BMI kg/m 2 [prevalence, 95%CI: 0.60 (0.34-0.86)] with random-effect model (I 2 = 0%). BMI < 25 kg/m 2 random effect models I 2 were negative, which indicates no observed heterogeneity for this group (Higgins 2003; Melsen et al. 2014 ).

This study summarized available studies from retrospective about BMI and COVID-19 infection. We observed prevalence rate from 0. 19%) . Similarly, other studies observed the relationship between weight gain with pneumonia (Baik et al. 2000) , infection rate among weight-reduced patients (Anderin et al. 2015) , and thromboembolic risk in obese (Kassir 2020) population. COVID-19 patient with high BMI has moderate to high risk of medical complication with infection; hence, their periodic health status of co-morbidities, e.g., hypertension and diabetes, should be evaluated. Also, there is geographical variation in fatality case rates in South Korea (0.8), China (2.3), and Italy (7.2) that has been reported (Onder et al. 2020) with risk factors of smoking, pollution, and aging. In US patients, < 60 years and with BMI 30-40 (OR (95%CI) 1.8: 1.2-2.7) were more likely to be admitted to acute and critical care to individuals with a BMI < 30 (Lighter et al. 2020a ) that has been reported for the first time. In a study, gender (male), age, and heart disease were the main risk factors of COVID-19-related death . Adolescents and young adults might play a key role in the worldwide spread of COVID-19 disease because they study overseas and frequently travel (Liao et al. (2020 (1) representativeness of the exposed cohort, (2) selection of the non-exposed cohort, (3) ascertain exposure, (4) demonstration that outcome of interest was not resent at stat of study; comparability; (5) comparability of cohorts on the basis of the design or analysis controlled for confounders; outcome: (6) assessment of outcome, (7) was followed up long enough for outcomes to occur, (8) adequacy of follow-up of cohorts. 

The BMI plays a significant role in COVID-19 infection and severity at all ages, especially elderly population. COVID-19 patients with higher BMI should be reviewed by a panel for the risk factors. Further, there should be a procedure for I 2 = 53.45%, p = <0.0001 increased vigilance, testing priority, and therapy for patients with obesity and COVID-19 disease, whose illness has entered 7-10 days, having age > 50 years, and elevated CRP levels. The severity of COVID-19 found has a significant burden on intensive care resources in hospitals worldwide and specifically in lower-and-middle income countries due to lack of health finance and resources. Hence, the patients having higher BMI with other comorbidities should be given special attention to reduce morbidity and mortality associated with COVID-19 infection.

Conflict of Interest The authors declare that they have no conflict of interest.

Weight loss before bariatric surgery and postoperative complications: data from the Scandinavian Obesity Registry (SOReg)

Impact of obesity and metabolic syndrome on immunity

Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis

A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women

Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK

COVID-19 in a designated infectious diseases hospital outside Hubei Province

Metabolic control of immune tolerance in health and autoimmunity

Association of body mass index with all-cause mortality in patients with diabetes: a systemic review and meta-analysis

Meta-analysis: overweight, obesity, and Parkinson's disease

The effect of endoscopic surveillance in patients with Barrett's esophagus: a systematic review and metaanalysis

Multivariate analysis of risk factors for deep and superficial sternal infection after coronary artery bypass grafting at a tertiary care medical center

COVID-19: Considerations for children and adolescents with diabetes

Body mass index and the risk of infectionfrom underweight to obesity

Body mass index and the risk of infections in institutionalised geriatric patients

Obesity and infection

Hospitalization rates and characteristics of patients hospitalized with laboratoryconfirmed coronavirus disease 2019-COVID-NET, 14 States

Link between metabolic syndrome and insulin resistance

The clinical characteristics and mortal causes analysis of COVID-19 death patients

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a metaanalysis

Risk factors associated with clinical outcomes in 323 COVID-19 patients in Wuhan

Obesity and nosocomial infections

Uncertainty in heterogeneity estimates in meta-analyses

Does COVID-19 disprove the obesity paradox in ARDS? Obesity

Risk of COVID-19 for patients with obesity

The immunomodulatory effects of physical activity

Well-being and immune response: a multi-system perspective

The case of the misleading funnel plot

Epidemiological and clinical characteristics of COVID-19 in adolescents and young adults

Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission

Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission

Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery

Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia

Obesity increases the duration of influenza A virus shedding in adults

The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses

Obesity increases mortality and modulates the lung metabolome during pandemic H1N1 influenza virus infection in mice

Obesity expands a distinct population of T cells in adipose tissue and increases vulnerability to infection

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis

Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A metaanalysis

Cigarette smoking and invasive pneumococcal disease

Risk factors for surgical site infection in spinal surgery

Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy

Diabetes and infection: assessing the association with glycaemic control in population-based studies

Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease

Epidemiological and clinical features of 2019-nCoV acute respiratory disease cases in Chongqing municipality

Adipose-lung cell crosstalk in the obesity-ARDS Paradox

The Lille intensive care COVID-19 and obesity study group (2020) High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Weight and prognosis for influenza A(H1N1)pdm09 infection during the pandemic period between 2009 and 2011: a systematic review of observational studies with meta-analysis

Impact of obesity on the risk of wound infection following surgery: results from a nationwide prospective multicentre cohort study in England

Obesity -a risk factor for postoperative complications in general surgery?

Cardiovascular consequences of metabolic syndrome

Effect of salmon consumption during pregnancy on maternal and infant faecal microbiota, secretory IgA and calprotectin

Surgical site infections at the National Cancer Institute in Mexico: a case-control study

Obesity and cancer risk: evidence, mechanisms, and recommendations: Obesity and cancer

Obesity and risk of sepsis: a population-based cohort study: Obesity and Risk of Sepsis

Newcastle-Ottawa quality assessment scale cohort studies

Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19)

Risk factors for severe corona virus disease 2019 (COVID-19) patients: a systematic review and meta analysis

Obesity and influenza Environ Sci Pollut Res associated mortality: evidence from an elderly cohort in Hong Kong

Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing

Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations